Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging.

BACKGROUND The assessment of return of function within dysfunctional myocardium after acute myocardial infarction (MI) using contractile reserve has been primarily qualitative. Magnetic resonance (MR) myocardial tagging is a novel noninvasive method that measures intramyocardial function. We hypothesized that MR tagging could be used to quantify the intramyocardial response to low-dose dobutamine and relate this response to return of function in patients after first MI. METHODS AND RESULTS Twenty patients with a first reperfused MI (age, 53+/-12 years; 16 male; 11 inferior MIs) were studied. Patients underwent breath-hold MR-tagged short-axis imaging on day 4+/-2 after MI at baseline and during dobutamine infusion at 5 and 10 microg x kg(-1) x min(-1). At 8+/-1 weeks after MI, patients returned for a follow-up MR tagging study without dobutamine. Quantification of percent intramyocardial circumferential segment shortening (%S) was performed. Low-dose dobutamine MRI was well tolerated. Overall, mean %S was 15+/-11% at baseline (n=227 segments), increased to 16+/-10% at 5 microg x kg(-1) x min(-1) dobutamine (P=NS), 21+/-10% at peak (P<0.0001 versus baseline and 5 microg x kg(-1) x min(-1), and 18+/-10% at 8 weeks (P<0.004 versus baseline and peak). The increase in %S with peak dobutamine was greater in dysfunctional myocardium (103 segments, +9+/-10%) than in normal tissue (124 segments, +4+/-12%, P<0.0001). In dysfunctional regions, %S also increased from 6+/-7% at baseline to 14+/-10% at 8 weeks after MI (P<0.0001). In dysfunctional regions that responded normally to peak dobutamine (> or =5% increase in %S), the increase in %S from baseline to 8 weeks after MI (+9+/-9%) was greater than in those regions that did not respond normally (+5+/-9%, P<0.04). Midmyocardial and subepicardial response to dobutamine were predictive of functional recovery, but the subendocardial response was not. CONCLUSIONS The response of intramyocardial function to low-dose dobutamine after reperfused MI can be quantified with MR tagging. Dysfunctional tissue after MI demonstrates a larger contractile response to dobutamine than normal myocardium. A normal increase in shortening elicited by dobutamine within dysfunctional midwall and subepicardium predicts greater functional recovery at 8 weeks after MI, but the response within the subendocardium is not predictive.

[1]  G M Hutchins,et al.  Two‐dimensional Echocardiography and Infarct Size: Relationship of Regional Wall Motion and Thickening to the Extent of Myocardial Infarction in the Dog , 1981, Circulation.

[2]  E. Braunwald,et al.  The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.

[3]  E. Zerhouni,et al.  Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion. , 1988, Radiology.

[4]  L. Axel,et al.  MR imaging of motion with spatial modulation of magnetization. , 1989, Radiology.

[5]  P. V. van Dijkman,et al.  Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction. , 1990, European journal of radiology.

[6]  P. Rigo,et al.  Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[7]  L Axel,et al.  Circumferential Myocardial Shortening in the Normal Human Left Ventricle: Assessment by Magnetic Resonance Imaging Using Spatial Modulation of Magnetization , 1991, Circulation.

[8]  E Picano,et al.  Stress echocardiography and the human factor: the importance of being expert. , 1990, Journal of the American College of Cardiology.

[9]  H Feigenbaum,et al.  Low‐Dose Dobutamine Echocardiography Detects Reversible Dysfunction After Thrombolytic Therapy of Acute Myocardial Infarction , 1993, Circulation.

[10]  Elliot R. McVeigh,et al.  Optimization of tag thickness for measuring position with magnetic resonance imaging , 1994, IEEE Trans. Medical Imaging.

[11]  M. Hori,et al.  Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. , 1994, Journal of the American College of Cardiology.

[12]  A. Maseri,et al.  Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. , 1994, The New England journal of medicine.

[13]  A. Young,et al.  Two‐dimensional Left Ventricular Deformation During Systole Using Magnetic Resonance Imaging With Spatial Modulation of Magnetization , 1994, Circulation.

[14]  S. Kaul,et al.  Dobutamine Echocardiography for Determining the Extent of Myocardial Salvage After Reperfusion: An Experimental Evaluation , 1994, Circulation.

[15]  A. Young,et al.  Three‐Dimensional Left Ventricular Deformation in Hypertrophic Cardiomyopathy , 1994, Circulation.

[16]  E. Atalar,et al.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.

[17]  A. Roos,et al.  Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. , 1995, American heart journal.

[18]  S. Kaul,et al.  There may be more to myocardial viability than meets the eye. , 1995, Circulation.

[19]  C. Kramer,et al.  Remote noninfarcted region dysfunction soon after first anterior myocardial infarction. A magnetic resonance tagging study. , 1996, Circulation.

[20]  The use of dobutamine stress echocardiography for the determination of myocardial viability , 1996, Clinical cardiology.

[21]  R Erbel,et al.  Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. , 1996, Journal of the American College of Cardiology.

[22]  P. Colonna,et al.  Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. , 1996, The American journal of cardiology.

[23]  K. Sagar,et al.  Dobutamine stress echocardiography for risk stratification after myocardial infarction. , 1997, Circulation.

[24]  D P Strum,et al.  Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiography. Comparison with sonomicrometry and pressure-volume relations. , 1997, Circulation.

[25]  W J Rogers,et al.  Breath-hold dobutamine magnetic resonance myocardial tagging: normal left ventricular response. , 1997, The American journal of cardiology.

[26]  C M Kramer,et al.  Usefulness of magnetic resonance imaging early after acute myocardial infarction. , 1997, The American journal of cardiology.

[27]  J. Murgo,et al.  Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from infarcted myocardium. , 1997, Journal of the American College of Cardiology.

[28]  R M Peshock,et al.  Dobutamine magnetic resonance imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization. , 1998, The American journal of cardiology.

[29]  C. Kramer,et al.  Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. , 1999, Circulation.